Synergic Effect of Methyl-β-Cyclodextrin and Hydrophilic Polymers on Nepafenac Solubilization: Development of a 0.3% Ophthalmic Solution
Nepafenac is an anti-inflammatory drug used in ophthalmology, marketed as a suspension due to its low aqueous solubility. A solution formulation could provide better bioavailability than suspension and facilitate single unit doses, avoiding the use of preservatives which are required to maintain ste...
Saved in:
| Main Authors: | Maria Grazia Saita, Fabiola Spitaleri, Katia Mangano, Danilo Aleo, Angela Patti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/15/3090 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Degradation products of nepafenac ophthalmic suspension and accurate structural characterization of 8-benzoyl-1,2-dihydrocinnolin-3(4H)-one through forced degradation and spectral studies.
by: Sandeep Zokande, et al.
Published: (2025-07-01) -
Comparison of The Effect of Topical Bromfenac With Nepafenac in Maintaining Mydriasis During Cataract Surgery
by: Garima Bansal, et al.
Published: (2015-10-01) -
Influence of combined eplerenone, aflibercept and nepafenac therapy on central serous chorioretinopathy
by: Wael Ahmed Ewais, et al.
Published: (2025-06-01) -
A Comparative Study of Topical Dexamethasone 0.1% and Topical Nepafenac 0.1% Ophthalmic Solutions in Cataract Patients Undergoing Manual Small Incision Cataract Surgery
by: VK Malik, et al.
Published: (2012-01-01) -
Comparison of topical nepafenac 0.1% and 0.3% on aqueous flare and macular thickness in patients with pseudoexfoliation following cataract surgery
by: Yusuf B Akbas, et al.
Published: (2025-06-01)